Today: 25 April 2026
Subscribe
Browse Category

Stock Market 14 December 2025

JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase shares closed Friday near $318, just below their 52-week high, after management projected 2026 expenses of about $105 billion—well above analyst expectations. The stock dropped 4–5% following the announcement, marking its sharpest decline in months. Investors are weighing the impact of increased spending on AI, marketing, and expansion ahead of upcoming earnings.
14 December 2025
··
GE Vernova Stock (GEV) News & Forecasts: Investor Update Rally Meets Valuation Reality as AI Power Demand Resets the Narrative

GE Vernova Stock (GEV) News & Forecasts: Investor Update Rally Meets Valuation Reality as AI Power Demand Resets the Narrative

GE Vernova stock hit a record $731.00 on Dec. 10 after the company raised 2026–2028 revenue and cash flow targets, doubled its dividend, and expanded buybacks. Shares then fell 4.61% to $671.71 by Dec. 12 as analysts debated future upside. Management now projects 2028 revenue of $52 billion. The company is also working with the U.S. government to address rare-earth supply risks.
14 December 2025
··
Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025)

Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025)

Eli Lilly shares last closed at $1,027.51 as investors weigh advances in obesity drugs and new manufacturing plans. Retatrutide, the company’s next-generation obesity treatment, showed 28.7% average weight loss in a Phase 3 trial, with more studies due in 2026. Lilly also announced a $6 billion API plant in Alabama. Orforglipron, an oral obesity drug, may see an accelerated FDA review.
14 December 2025
··
Lululemon Stock (NASDAQ: LULU) News, Forecasts and Analysis for Dec. 14, 2025: CEO Exit, Q3 Beat, Buyback Boost and Nasdaq-100 Removal

Lululemon Stock (NASDAQ: LULU) News, Forecasts and Analysis for Dec. 14, 2025: CEO Exit, Q3 Beat, Buyback Boost and Nasdaq-100 Removal

Lululemon said CEO Calvin McDonald will step down in January 2026 and reported Q3 revenue up 7% to $2.6 billion, with international sales rising 33% but Americas revenue down 2%. The company will be removed from the Nasdaq-100 on December 22, 2025. Shares traded near $204.97 after the news. Gross margin fell to 55.6%, and operating income dropped 11%.
14 December 2025
·
Costco Stock (COST) News, Forecasts and Analyst Targets for Dec. 14, 2025: Earnings Beat, Valuation Debate, and Tariff Lawsuit in Focus

Costco Stock (COST) News, Forecasts and Analyst Targets for Dec. 14, 2025: Earnings Beat, Valuation Debate, and Tariff Lawsuit in Focus

Costco closed at about $884 on Friday, Dec. 12, 2025, after reporting Q1 FY2026 net sales of $65.98 billion, up 8.2% year over year, and diluted EPS of $4.50. Shares traded in the high-$860s to high-$880s for the week, with muted reaction despite the earnings beat. Investors are watching valuation debates and a pending tariff lawsuit.
14 December 2025
··
Netflix Stock (NFLX) Forecast and News: Warner Bros Deal, Paramount Hostile Bid, and Analyst Targets as of Dec. 14, 2025

Netflix Stock (NFLX) Forecast and News: Warner Bros Deal, Paramount Hostile Bid, and Analyst Targets as of Dec. 14, 2025

Netflix closed at $95.19 on Friday, down nearly 14.5% over the past month, as investors react to its $82.7 billion bid for Warner Bros. Discovery’s studios and streaming assets. Paramount launched a hostile counterbid, escalating the deal’s antitrust and political risks. The proposed transaction would give WBD shareholders $23.25 in cash and $4.50 in Netflix stock per share. Completion depends on regulatory and shareholder approval.
14 December 2025
···
Micron Technology (MU) Stock News and Forecast for Dec. 14, 2025: Earnings Countdown, AI Memory Shortage, and Wall Street’s New Price Targets

Micron Technology (MU) Stock News and Forecast for Dec. 14, 2025: Earnings Countdown, AI Memory Shortage, and Wall Street’s New Price Targets

Micron shares closed at $241.14 on Friday, Dec. 12, 2025, down 6.7% ahead of its earnings report scheduled for Dec. 17. The company faces high expectations amid a global memory supply crunch driven by AI demand, with analysts raising targets and options markets pricing in a possible double-digit move post-earnings. Investors are watching HBM and DRAM pricing, gross margins, and 2026 supply signals.
14 December 2025
····
Alphabet Class C Stock (GOOG) News and Forecasts: AI Overviews, Cloud Capex, and Antitrust Risks (Dec. 14, 2025)

Alphabet Class C Stock (GOOG) News and Forecasts: AI Overviews, Cloud Capex, and Antitrust Risks (Dec. 14, 2025)

Alphabet’s GOOG shares hovered near $310, just below a recent 52-week high, with a market value close to $2.94 trillion. Investors weighed strong AI and cloud growth against mounting antitrust scrutiny in the EU and U.S. The European Commission opened a new probe into Google’s use of publisher content for AI, raising concerns over compensation and opt-out options.
14 December 2025
····
Palantir (PLTR) Stock News & Forecasts for Dec. 14, 2025: $448M Navy ShipOS, Nvidia “Chain Reaction,” and What Analysts See Next

Palantir (PLTR) Stock News & Forecasts for Dec. 14, 2025: $448M Navy ShipOS, Nvidia “Chain Reaction,” and What Analysts See Next

Palantir closed at $183.57 on Dec. 12, 2025, down 2.12% after a volatile week. The company secured a U.S. Navy ShipOS contract worth up to $448 million and announced a new AI infrastructure platform with Nvidia and CenterPoint. Palantir also filed a lawsuit against a rival startup. Market cap stands at $437.53 billion, with shares up 153% over the past year.
14 December 2025
·
AMD Stock News and Forecasts (Dec. 14, 2025): What’s Driving Advanced Micro Devices (NASDAQ: AMD) and What Analysts Expect Next

AMD Stock News and Forecasts (Dec. 14, 2025): What’s Driving Advanced Micro Devices (NASDAQ: AMD) and What Analysts Expect Next

AMD shares closed at $210.78 on Dec. 14, down 4.8% after a volatile session tied to a broader selloff in AI-related hardware stocks. The drop followed margin warnings from Broadcom and spending concerns at Oracle, which triggered a wider retreat in the sector. No AMD-specific news drove the decline. Investors remain focused on AI demand and upcoming earnings.
14 December 2025
··
Amazon Stock (AMZN) News, Forecasts, and Analyst Outlook on Dec. 14, 2025: OpenAI Deal, AWS re:Invent AI Push, and What Investors Are Watching

Amazon Stock (AMZN) News, Forecasts, and Analyst Outlook on Dec. 14, 2025: OpenAI Deal, AWS re:Invent AI Push, and What Investors Are Watching

Amazon.com shares closed at $226.19 on Dec. 12, 2025, up 3.1% year-to-date but below the 52-week high of $258.60. Investors are weighing strong AI-driven cloud demand against rising infrastructure costs. A $38 billion, seven-year AWS deal with OpenAI was announced in November. Regulatory issues and delivery cost concerns remain in focus.
14 December 2025
···
Microsoft Stock (MSFT) News, Forecasts & Analysis for Dec. 14, 2025: AI Mega-Investments, Azure Momentum, and Wall Street’s $630–$650 Targets

Microsoft Stock (MSFT) News, Forecasts & Analysis for Dec. 14, 2025: AI Mega-Investments, Azure Momentum, and Wall Street’s $630–$650 Targets

Microsoft shares last traded near $478.53 as of Dec. 14, 2025, after announcing $23 billion in new AI infrastructure spending, including $17.5 billion for India and $5.4 billion for Canada. The stock remains volatile, with a 52-week range from $344.79 to $555.45. Investors are weighing rising capital expenditures against strong Azure and Copilot demand.
14 December 2025
···
Oracle Stock (ORCL) Outlook on Dec. 14, 2025: AI Spending Shock, OpenAI Data Center Delays, and Wall Street Forecasts

Oracle Stock (ORCL) Outlook on Dec. 14, 2025: AI Spending Shock, OpenAI Data Center Delays, and Wall Street Forecasts

Oracle shares closed at $189.97, down 4.56% after fiscal Q2 results beat earnings estimates but raised concerns over AI infrastructure spending and slower revenue conversion. Analyst consensus remains “Moderate Buy,” with average 12-month price targets near $300. Oracle’s Q3 guidance missed expectations, projecting adjusted EPS of $1.64–$1.68 and revenue growth of 16%–18%.
14 December 2025
··
NVIDIA Stock (NVDA) News Today: China H200 Export Shift, AI Spending Jitters, and Wall Street Forecasts (Dec. 14, 2025)

NVIDIA Stock (NVDA) News Today: China H200 Export Shift, AI Spending Jitters, and Wall Street Forecasts (Dec. 14, 2025)

Nvidia shares closed Friday at $175.02 after a volatile week for AI chip stocks. The U.S. will allow exports of Nvidia’s H200 AI processors to China with a 25% import fee, but not its newest Blackwell or Rubin chips. Nvidia is considering increasing H200 production as Chinese demand exceeds supply. The Commerce Department is finalizing export terms.
14 December 2025
·
Tesla Stock News and Forecasts for Dec. 14, 2025: Robotaxi Countdown, Sales Signals, and Wall Street Targets for TSLA

Tesla Stock News and Forecasts for Dec. 14, 2025: Robotaxi Countdown, Sales Signals, and Wall Street Targets for TSLA

Tesla closed Friday at $458.96, rising 2.7% amid renewed focus on autonomy and robotics. Elon Musk said Tesla may remove safety monitors from its Austin robotaxi fleet within three weeks. U.S. November sales dropped nearly 23% year over year to about 39,800 vehicles, the lowest since early 2022. A recent analyst downgrade has fueled debate over the company’s valuation.
14 December 2025
···
Exxon Mobil (XOM) Stock Outlook: 2030 Plan Lifts Targets, Analysts Raise Price Goals — What to Watch This Week (Updated Dec. 14, 2025)

Exxon Mobil (XOM) Stock Outlook: 2030 Plan Lifts Targets, Analysts Raise Price Goals — What to Watch This Week (Updated Dec. 14, 2025)

Exxon Mobil shares rallied midweek after the company raised its 2030 earnings and cash flow targets while keeping capital spending flat. XOM last traded near $118.82. The plan calls for $25 billion in earnings growth and $35 billion in cash flow by 2030, with annual capex held at $28–$33 billion. Shares steadied just below $120 by Friday’s close.
14 December 2025
··
Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Novo Nordisk shares rebounded this week, rising about 7% in both Copenhagen and U.S. trading after EU regulators backed a higher-dose Wegovy, Ozempic launched in India at a lower price, and the company closed its Akero Therapeutics acquisition. The week began with a sharp selloff on competition fears and a Wall Street downgrade before sentiment reversed midweek.
14 December 2025
····
IonQ (IONQ) Stock Outlook: This Week’s News, Analyst Targets, and What to Watch Next Week (Updated Dec. 14, 2025)

IonQ (IONQ) Stock Outlook: This Week’s News, Analyst Targets, and What to Watch Next Week (Updated Dec. 14, 2025)

IonQ shares fell 7.4% to $50.35 for the week ending Dec. 12 after sharp swings, including heavy declines on Dec. 10 and Dec. 12. The company announced Slovakia’s first national quantum communication network on Dec. 8, built with its subsidiary ID Quantique and local partners. Trading volume spiked above normal levels on several days.
14 December 2025
··
Ondas Holdings (ONDS) Stock: Key News, Price Action, Analyst Targets, and What to Watch Next Week (Updated Dec. 14, 2025)

Ondas Holdings (ONDS) Stock: Key News, Price Action, Analyst Targets, and What to Watch Next Week (Updated Dec. 14, 2025)

Ondas Holdings (NASDAQ: ONDS) closed at $8.75 on Dec. 12, down 3% for the week after volatile trading and heavy volume. The company disclosed a $5.2 million debt exchange and expects a $56.6–$60.5 million non-cash Q4 charge. Director Ron Stern resigned. Ondas announced plans to invest up to $11 million in Ukrainian drone firm Drone Fight Group.
14 December 2025
·
1 … 964 965 966 967 968 … 1,389

Stock Market Today

  • AstraZeneca Share Price Pullback: Attractive Buy or Overvalued?
    April 25, 2026, 1:29 PM EDT. AstraZeneca (LSE:AZN) shares dropped 7.7% in the past week, closing at £139.56. Despite this, it's gained 36.5% over the past year. A discounted cash flow (DCF) analysis values AstraZeneca at around US$237.83 per share, implying the stock trades at a 41.3% discount to intrinsic value, suggesting it is undervalued. The company's free cash flow is projected to rise from US$9.49 billion to US$20.18 billion by 2030. Market sentiment is influenced by its pharmaceutical pipeline and regulatory developments. AstraZeneca's price-to-earnings (P/E) ratio remains a key metric for evaluating growth expectations. Investors should weigh recent declines against long-term fundamentals and risks to determine potential value in the stock.

Latest article

US Stock Market This Week: S&P 500, Nasdaq Hit Records as Intel Sparks AI Rally

US Stock Market This Week: S&P 500, Nasdaq Hit Records as Intel Sparks AI Rally

25 April 2026
The S&P 500 and Nasdaq closed at record highs Friday, lifted by a surge in chip stocks after Intel’s strong forecast. The Dow slipped 0.16%. Intel’s revenue and outlook beat estimates, sending its shares and peers like AMD and Nvidia sharply higher. IBM and ServiceNow weighed on software stocks, highlighting uneven performance across sectors.
Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

Sirius XM Holdings Inc. Deal Talks With iHeartMedia Could Reshape U.S. Audio Market

25 April 2026
SiriusXM is in early merger talks with iHeartMedia, Bloomberg reported Friday, potentially combining the largest U.S. satellite-radio and broadcast-radio companies. SiriusXM shares fell nearly 5% while iHeartMedia surged 35% on deal speculation. Both firms declined to comment. SiriusXM reports first-quarter results April 30, with investors watching subscriber and ad trends.
Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

Shake Shack Stock Gets a Fresh Wall Street Boost Before Earnings. Here’s What Changed

25 April 2026
Guggenheim initiated Shake Shack at Buy with a $120 price target, citing margin upside and expansion potential. Shares rose 5.6% to $103.02. The call comes ahead of Shake Shack’s May 7 earnings report, with recent data showing first-quarter visits up nearly 20% year-over-year. JPMorgan raised its target to $100 but kept a Neutral rating, reflecting mixed analyst sentiment.
Go toTop